Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression Fulminant type 1 diabetes vs classical type 1A diabetes

ABSTRACT: We determined the genes that were differentially expressed between fulminant type 1 diabetes and classical type 1A diabetes using gene expression microarray in peripheral blood cells.

ORGANISM(S): Homo sapiens

PROVIDER: GSE44313 | GEO | 2014/01/01

SECONDARY ACCESSION(S): PRJNA189468

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Gene expression Fulminant type 1 diabetes vs classical type 1A diabetes

Project description:We determined the genes that were differentially expressed between fulminant type 1 diabetes and classical type 1A diabetes using gene expression microarray in peripheral blood cells. Ten patients with type 1 diabetes (5 fulminant and 5 classical type 1A) were enrolled in this study. All patients had recovered from ketosis or ketoacidosis at disease onset and had been receiving intensive insulin injection therapy for at least 1 month, which means that all patients and healthy controls were free of metabolic derangements at the time of blood sampling. To determine the genes that were differentially expressed between classical type 1A and fulminant type 1 diabetes, a volcano plot analysis (fold change >1.5 and p-value <0.05) was performed.

2014-01-01 | E-GEOD-44313 | biostudies-arrayexpress

gene expression Fulminant type 1 diabetes vs classical type 1A diabetes vs healthy controls

Project description:We determined the genes that were differentially expressed between fulminant type 1 diabetes and classical type 1A diabetes or healthy control using gene expression microarray in peripheral blood cells. Ten patients with type 1 diabetes (5 fulminant and 5 classical type 1A) and 6 healthy controls were enrolled in this study. All patients had recovered from ketosis or ketoacidosis at disease onset and had been receiving intensive insulin injection therapy for at least 1 month, which means that all patients and healthy controls were free of metabolic derangements at the time of blood sampling. To determine the genes that were differentially expressed among fulminant type 1 diabetes, classical type 1A and healthy controls, a volcano plot analysis (fold change >1.5 and p-value <0.05) was performed.

2014-01-01 | E-GEOD-44314 | biostudies-arrayexpress

gene expression Fulminant type 1 diabetes vs classical type 1A diabetes vs healthy controls

2014-01-01 | GSE44314 | GEO

Homo sapiens

Project description:Gene expression Fulminant type 1 diabetes vs classical type 1A diabetes

| PRJNA189468 | ENA

Homo sapiens

Project description:gene expression Fulminant type 1 diabetes vs classical type 1A diabetes vs healthy controls

| PRJNA189469 | ENA

Go Type 2 Diabetes

Project description:Go Type 2 Diabetes

| PRJNA268369 | ENA

Methylation arrays (MethylationEPIC) of whole blood of individuals with type 1 diabetes

Project description:Type 1 diabetes (1a) diabetes is an autoimmune disease in which both environmental and genetic factors play a role. Epigenetic marks such as DNA methylation, being molecular links between the environment and the genome function, are sound candidates for the explanation of part of the aetiology and mechanisms of the disease. Here, the methylomes of the whole blood of 18 adult individuals with T1D were profiled using Illumina's MethylationEPIC array technology.

2020-12-22 | E-MTAB-8694 | biostudies-arrayexpress

ConA-induced fulminant hepatitis in a mouse model

Project description:The goal of this experiment was to investigate the early mechanisms of human fulminant hepatitis through ConA-induced hepatitis model.Early diagnosis and interventions are important for patients with fulminant hepatitis and gene expression may be pivotal in the early diagnosis. Keyword :ConA-induced hepatitis model

2009-07-21 | GSE17184 | GEO

Bj Paraquat fulminant shock vs. non-treatment

Project description:Genome-wide transcriptional profiling of cells subjected to a paraquat fulminant shock treatment (5mM for 10 minutes).

2011-05-16 | GSE26236 | GEO

Ang II type 1a receptor in Marfan syndrome

Project description:Ang II type 1a receptor in Marfan syndrome

| PRJNA432050 | ENA